RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > China's FDA Announces New Administrative Review Process

China's FDA Announces New Administrative Review Process

Posted 13 November 2013 | By Louise Zornoza

China's FDA (CFDA) issued a notice on 6 November 2013 establishing a new administrative review process to take effect as of 1 January 2014 allowing entities to appeal decisions.

A requested review must allege that the specific administrative acts infringe upon the legitimate rights and interests of citizens, legal persons or other entities. The burden will be on the applicant to establish the factual and legal basis for the reconsideration of a specific administrative act.  Regulators said the administrative review process will be lawful, fair, open and timely, and that the cost of the process will be borne by the CFDA.

CFDA Notice

Read all Breaking News from Reglink


© 2022 Regulatory Affairs Professionals Society.